Ursal, Mary Jane .
HRN: 07-44-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
CEFUROXIME 500MG (TAB)
03/25/2024
04/01/2024
PO
500 Mg Tab
BID
S/P Excision Of Pedunculated Left Labia Majora Mass
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes